rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Armata Pharmaceuticals, Inc.

ARMP · NYSE American

Health CareBiotechnology

We hold no 150-day reading for ARMP yet: it needs about 200 sessions of history. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
54 (+10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders54+10 on the quarter
New · exited20 · 10
Reported value$32.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Madison Asset Management, LLCreduced · filed 10 Aug 20262,107,175$13.7M-5000.0%
BlackRock, Inc.added · filed 7 Aug 2026559,986$3.6M+494,936+760.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026487,968$3.2M+121,940+33.3%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026470,500$3.0M+212,508+82.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026270,550$1.8M+155,995+136.2%
Dauntless Investment Group, LLCadded · filed 13 Aug 2026203,891$1.3M+113,311+125.1%
STATE STREET CORPadded · filed 7 Aug 2026129,600$840K+78,800+155.1%
NORTHERN TRUST CORPadded · filed 13 Aug 202689,791$582K+65,145+264.3%
VANGUARD PORTFOLIO MANAGEMENT LLCnew · filed 13 Aug 202681,354$527K+81,354
EDGEWOOD MANAGEMENT LLCreduced · filed 13 Aug 202680,000$518K-20,000−20.0%
31 Mar 2023 – 30 Jun 2026
183653Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Deborah Birx Company insiderChief Executive Officer · last 10 Jul 20260 · 0
Daniel B. Gilmer Company insiderDirector · last 24 Apr 20260 · 0
Pierre Kyme Company insiderChief Business Officer · last 14 Mar 20260 · 0
David Duane House Company insiderSVP, Finance, and PFO · last 9 Mar 20260 · 0
Joseph M. Patti Company insiderDirector · last 9 Mar 20260 · 0
Jules Haimovitz Company insiderDirector · last 9 Mar 20260 · 0
Kostas D. Odysseas Company insiderDirector · last 9 Mar 20260 · 0
Robin Kramer Company insiderDirector · last 9 Mar 20260 · 0
Sarah J. Schlesinger Company insiderDirector · last 9 Mar 20260 · 0
Todd C. Peterson Company insiderDirector · last 9 Mar 20260 · 0
Richard Rychlik Company insiderCorporate Controller and PFO · last 14 Mar 20240 · 0
Innoviva Strategic Opportunities Llc Company insiderDirector, 10% owner · last 10 Jan 20233 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-53.9%
Share count trendFY 2025 · to 18 Mar 20260.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.7M
Free cash flowFY 2025 · to 31 Dec 2025−$26.3M

Analyst forecasts

No analyst forecasts yet.